Relay Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RLAY research report →
About the company
Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials. Its central mission involves revolutionizing the drug discovery process, with a particular focus on enhancing the creation of small molecule therapies for specific types of cancer and genetic conditions.
- CEO
- Sanjiv K. Patel
- IPO
- 2020
- Employees
- 259
- HQ
- Cambridge, MA, US
Price Chart
- Market Cap
- $3.26B
- P/E
- -11.88
- P/S
- 305.71
- P/B
- 5.22
- EV/EBITDA
- -11.31
- Div Yield
- 0.00%
- Gross Margin
- -546.17%
- Op Margin
- -2776.61%
- Net Margin
- -2554.14%
- ROE
- -43.94%
- ROIC
- -44.00%
- Revenue
- $15.36M · 53.44%
- Net Income
- $-276,479,000 · 18.13%
- EPS
- $-1.61 · 31.78%
- Op Income
- $-302,738,000
- FCF YoY
- 6.08%
- 52W High
- $19.93
- 52W Low
- $3.02
- 50D MA
- $14.62
- 200D MA
- $9.95
- Beta
- 1.68
- Avg Volume
- 4.27M
Get TickerSpark's AI analysis on RLAY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 26 | Rahmer Peter | other | 3,056 |
| Jun 30, 26 | Rahmer Peter | sell | 50,000 |
| Jun 22, 26 | Catinazzo Thomas | other | 61,563 |
| Jun 22, 26 | Catinazzo Thomas | other | 56,323 |
| Jun 22, 26 | Catinazzo Thomas | other | 51,560 |
| Jun 22, 26 | Catinazzo Thomas | other | 51,560 |
| Jun 22, 26 | Catinazzo Thomas | sell | 17,717 |
| Jun 22, 26 | Catinazzo Thomas | sell | 51,560 |
| Jun 22, 26 | Catinazzo Thomas | other | 61,563 |
| Jun 22, 26 | Catinazzo Thomas | other | 56,323 |
Our RLAY coverage
Recent articles, reports, and earnings notes.
No research on RLAY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RLAY report →Similar companies
Peers in the same neighborhood.